Why NEOG beats the market
Up 95% in a year while the S&P 500 rose 7%.
- Its loss narrowed from $1.09B in fiscal 2025 to $7.9M in fiscal 2026; free cash flow went from -$46.4M to $31.9M.
NEOG's Quality Score fell 2 points on Fri, Nov 20, to 0. Its price fell below its average of the last 200 days.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 95% in a year while the S&P 500 rose 7%.
| Since its Dec 2021 high | Down 77% |
| Latest filing | 8-K, Oct 26 |
After its last 4 reports it closed +12.2% on average, higher 2 of 4 times.
Below Averagefor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means
Well below its recent run. NEOG scores 0 today, against a median of 5 over its last 20 recorded sessions.
NEOG is #40 of 89 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 40 |
Expected to report Thu Jan 7, after the close (in 47 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $222.8M; a loss of $0.05 a share.
| Line | Q1 FY27 | Q1 FY26 |
|---|---|---|
| Product | $196M | $184M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 7)
| Measure | Figure |
|---|---|
| Total revenue | $885M to $890M |
Sales grew 13% a year over 5 years, fiscal 2021 to 2026.
Its share count grew 4.8% a year over 3 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Oct 6, 2026 | +5.4% | -2.3% | -1.9% |
| Jul 30, 2026 | +11.7% | +22.7% | +21.3% |
| Apr 9, 2026 | -11.0% | -3.0% | -8.9% |
| Jan 8, 2026 | +25.2% | +31.6% | +27.2% |
Sales grew in five of the last seven years, to $870M in 2026. It made a profit in four of the eight years.
RSI 34.1, MACD below signal, below its 50-day, above its 200-day. Not scored.
One insider bought $10K across 2 filings, and one insider sold $115K across 1 filing, in the last 6 months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: NEOG is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.
“While competitors differ across individual markets, we are not aware of any single competitor that is pursuing Neogen’s fundamental strategy of developing and marketing a broad line of products, ranging from disposable tests and culture media to veterinary pharmaceuticals and instruments for a large number of food safety and animal safety concerns.”
NEOG scores 0 today, which Breakaway calls Below Average. It is #40 of 89 in Pharma by Quality Score, with 1 of 14 chart checks firing. Up 95% in a year while the S&P 500 rose 7%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
NEOG scores 0 today, which Breakaway calls Below Average (0 to 5). That is #40 of 89 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind NEOG's 0.
One insider bought $10K across 2 filings, and one insider sold $115K across 1 filing, in the last 6 months. The newest is Jeremy Yarwood, Chief Scientific Officer, who sold $115K on Nov 4. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Only on the public pages, which run at least 15 minutes behind. Pro members see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included. The one stock you open in full is live too.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Tuesday morning. No account. No card.One stock in full, free. No account.$1 for a first month of Pro. Then $39 a month. Then keep going with a free account.Then $1 for a first month of Pro.Then 7 days of Pro free, with a card.